SI-BONE, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
SI-BONE, Inc. (SIBN) holds an ST Score of 68.6 out of 100 (B+), with its strongest factor being Momentum (A) and its weakest Forecast (B-). Analysts rate SIBN Buy across 10 ratings with a $23.00 average price target (+0.3% vs the current $18.09).
- Strongest
- MomentumA
- Weakest
- ForecastB-
All factor grades
- MomentumA
- ProfitabilityA-
- Financial StrengthB+
- GrowthB+
- ValuationB
- ForecastB-
- Piotroski5/9
Contact
SIBN stock: frequently asked questions
What is SIBN's ST Score?
SI-BONE, Inc. (SIBN) has an ST Score of 68.6 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SIBN a buy, sell, or hold?
Wall Street's consensus rating on SIBN is Buy based on 10 analyst ratings. Our own ST Score grades it B+ (68.6/100). This is data, not investment advice — always do your own research.
What is SIBN's valuation grade?
SI-BONE, Inc. (SIBN) earns a valuation grade of B, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SIBN's growth grade?
SI-BONE, Inc. (SIBN) earns a growth grade of B+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SIBN's profitability grade?
SI-BONE, Inc. (SIBN) earns a profitability grade of A-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SIBN's financial strength grade?
SI-BONE, Inc. (SIBN) earns a financial strength grade of B+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SIBN?
The average analyst price target for SI-BONE, Inc. (SIBN) is $23.00 from 10 analysts, which is +0.3% versus the recent price of $18.09.
What is SIBN's Piotroski score?
SI-BONE, Inc. (SIBN) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.